Fred Hutch
@fredhutch.org
Making life beyond cancer a reality. fredhutch.org
Reposted by Fred Hutch
Zanubrutinib Plus Venetoclax Displays Long-Term PFS Benefit in Untreated CLL/SLL @ash.hematology.org @fredhutch.org @mshadman.bsky.social #ASH25 #oncology #leusm #lymsm
www.onclive.com/view/zanubru...
www.onclive.com/view/zanubru...
Zanubrutinib Plus Venetoclax Displays Long-Term PFS Benefit in Untreated CLL/SLL | OncLive
Zanubrutinib plus venetoclax maintained a 36-month PFS rate of 87% (95% CI, 78.6%–92.4%) in treatment-naive CLL/SLL.
www.onclive.com
December 9, 2025 at 4:05 PM
Zanubrutinib Plus Venetoclax Displays Long-Term PFS Benefit in Untreated CLL/SLL @ash.hematology.org @fredhutch.org @mshadman.bsky.social #ASH25 #oncology #leusm #lymsm
www.onclive.com/view/zanubru...
www.onclive.com/view/zanubru...
Reposted by Fred Hutch
Today we celebrated the retirement of research administration manager Katrina Akioka after 13 years @fredhutch.org. She leaves behind a legacy of service to Fred Hutch, the division, and the many faculty and labs she supported over the years. We wish her all the best in retirement.
December 9, 2025 at 1:12 AM
Today we celebrated the retirement of research administration manager Katrina Akioka after 13 years @fredhutch.org. She leaves behind a legacy of service to Fred Hutch, the division, and the many faculty and labs she supported over the years. We wish her all the best in retirement.
Fred Hutch #BMT and #GVHD expert Dr. Geoffrey Hill spoke to Fred Hutch News about the lifesaving strides that have been made in GVHD treatment, and where the research is focused next. Read more: https://bit.ly/48FyccO
December 9, 2025 at 5:10 PM
Fred Hutch #BMT and #GVHD expert Dr. Geoffrey Hill spoke to Fred Hutch News about the lifesaving strides that have been made in GVHD treatment, and where the research is focused next. Read more: https://bit.ly/48FyccO
Reposted by Fred Hutch
Catching up at #ash25 with 2 great scientists @fredhutch.org Kate Markey & @mskcancercenter.bsky.social Susan Dewolf
December 8, 2025 at 2:06 PM
Catching up at #ash25 with 2 great scientists @fredhutch.org Kate Markey & @mskcancercenter.bsky.social Susan Dewolf
Fred Hutch at #ASH25: Catch Dr. Stefan Radtke present "In Vivo hematopoietic stem cell (#HSC) engineering and selection with CD90-targeted multiplexed virus-like particles (MVPs) for HSC #genetherapy and cancer #immunotherapy" 👉 https://bit.ly/4pTX3AA
December 8, 2025 at 9:00 PM
Fred Hutch at #ASH25: Catch Dr. Stefan Radtke present "In Vivo hematopoietic stem cell (#HSC) engineering and selection with CD90-targeted multiplexed virus-like particles (MVPs) for HSC #genetherapy and cancer #immunotherapy" 👉 https://bit.ly/4pTX3AA
Fred Hutch at #ASH25: Catch Dr. Mazyar Shadman present "CAR T cell therapy referral patterns and characteristics of patients with relapsed or refractory (R/R) large B cell lymphoma (LBCL) in the United States" 👉 https://bit.ly/3MFUO5i
December 8, 2025 at 8:25 PM
Fred Hutch at #ASH25: Catch Dr. Mazyar Shadman present "CAR T cell therapy referral patterns and characteristics of patients with relapsed or refractory (R/R) large B cell lymphoma (LBCL) in the United States" 👉 https://bit.ly/3MFUO5i
Fred Hutch at #ASH25: Catch Dr. Emily Liang present "High-dose anakinra to treat refractory immune effector cell-associated neurotoxicity syndrome in #CARTcelltherapy recipients" 👉 https://bit.ly/4rCgeQL
December 8, 2025 at 6:10 PM
Fred Hutch at #ASH25: Catch Dr. Emily Liang present "High-dose anakinra to treat refractory immune effector cell-associated neurotoxicity syndrome in #CARTcelltherapy recipients" 👉 https://bit.ly/4rCgeQL
Fred Hutch at #ASH25: Catch Dr. Jennifer Huang present "Superior real-world outcomes of lisocabtagene maraleucel in chronic lymphocytic #leukemia" #CLL 👉 https://bit.ly/4rTooEO
December 8, 2025 at 2:51 PM
Fred Hutch at #ASH25: Catch Dr. Jennifer Huang present "Superior real-world outcomes of lisocabtagene maraleucel in chronic lymphocytic #leukemia" #CLL 👉 https://bit.ly/4rTooEO
Fred Hutch's Min Fang presenting work at #ASH25 showing chromosome genomic array testing (CGAT) improves diagnostic yield in patients with #AML and #MDS and has the potential for better risk stratification - an NCI myeloMATCH and @swog.org report. ashpublications.org/blood/articl...
December 8, 2025 at 12:23 AM
Fred Hutch's Min Fang presenting work at #ASH25 showing chromosome genomic array testing (CGAT) improves diagnostic yield in patients with #AML and #MDS and has the potential for better risk stratification - an NCI myeloMATCH and @swog.org report. ashpublications.org/blood/articl...
Fred Hutch's Xiaoyu Qu presenting work at #ASH25 on improving karyotype success for myeloMATCH. Enhanced workflows boosted karyotype yield in AML samples, ensuring more patients receive accurate cytogenetic data for precision trial enrollment. ashpublications.org/blood/articl...
December 8, 2025 at 12:21 AM
Fred Hutch's Xiaoyu Qu presenting work at #ASH25 on improving karyotype success for myeloMATCH. Enhanced workflows boosted karyotype yield in AML samples, ensuring more patients receive accurate cytogenetic data for precision trial enrollment. ashpublications.org/blood/articl...
Fred Hutch at #ASH25: Dr. Danielle Kirkey & team identified CLEC2A as a cancer-specific antigen in AML — silent in normal cells, enriched in high-risk KMT2A-r AML. CLEC2A CAR T cells showed strong preclinical efficacy & head to clinical trials in 2026. #AML #CARTherapy
December 8, 2025 at 12:21 AM
Fred Hutch at #ASH25: Dr. Danielle Kirkey & team identified CLEC2A as a cancer-specific antigen in AML — silent in normal cells, enriched in high-risk KMT2A-r AML. CLEC2A CAR T cells showed strong preclinical efficacy & head to clinical trials in 2026. #AML #CARTherapy
Reposted by Fred Hutch
Congrats to Dr. Storb recipient of the Wallace H. Coulter Award for Lifetime Achievement in Hematology. Dr. Storb is recognized for more than 60 years of pioneering work that shaped hematopoietic stem cell transplantation & advanced care of patients with blood disorders. #ASH25 #HemeSky
December 7, 2025 at 6:51 PM
Fred Hutch at #ASH25: Catch Rasika Venkataraman present "DDX41-R525H mutation promotes dysplastic hematopoiesis via aberrant splicing of key regulators of HSC biology" 👉 https://bit.ly/4iBRuUJ
December 7, 2025 at 9:00 PM
Fred Hutch at #ASH25: Catch Rasika Venkataraman present "DDX41-R525H mutation promotes dysplastic hematopoiesis via aberrant splicing of key regulators of HSC biology" 👉 https://bit.ly/4iBRuUJ
Reposted by Fred Hutch
Congrats to Fred Hutch #HSCT pioneer Dr. Rainer Storb on receiving the Wallace H. Coulter Award for Lifetime Achievement in Hematology at #ASH25! 🩸 👉 bit.ly/3MkdPdx
December 7, 2025 at 7:26 PM
Congrats to Fred Hutch #HSCT pioneer Dr. Rainer Storb on receiving the Wallace H. Coulter Award for Lifetime Achievement in Hematology at #ASH25! 🩸 👉 bit.ly/3MkdPdx
December 7, 2025 at 7:24 PM
Congrats to Fred Hutch #HSCT pioneer Dr. Rainer Storb on receiving the Wallace H. Coulter Award for Lifetime Achievement in Hematology at #ASH25! 🩸 👉 bit.ly/3MkdPdx
Fred Hutch at #ASH25: Catch @julieboiko.bsky.social present "CSF-1R+ macrophages orchestrate human skin chronic graft-versus-host disease" 👉 https://bit.ly/48jvqLc
December 7, 2025 at 5:14 PM
Fred Hutch at #ASH25: Catch @julieboiko.bsky.social present "CSF-1R+ macrophages orchestrate human skin chronic graft-versus-host disease" 👉 https://bit.ly/48jvqLc
Fred Hutch at #ASH25: Don't miss #HSCT pioneer Dr. Rainer Storb receive the Wallace H. Coulter Award for Lifetime Achievement in Hematology! 🩸 👉 https://bit.ly/3MkdPdx
December 7, 2025 at 4:30 PM
Fred Hutch at #ASH25: Don't miss #HSCT pioneer Dr. Rainer Storb receive the Wallace H. Coulter Award for Lifetime Achievement in Hematology! 🩸 👉 https://bit.ly/3MkdPdx
Reposted by Fred Hutch
Congratulations to Aida de la Cruz, lab manager in the @harmitmalik.bsky.social Lab, on receiving the Hutchison Award! The award, presented by @fredhutch.org SPAC and named for Dr. Nancy Hutchison, recognizes phenomenal mentorship. It also comes with an awesome personalized bobblehead.
December 5, 2025 at 9:30 PM
Congratulations to Aida de la Cruz, lab manager in the @harmitmalik.bsky.social Lab, on receiving the Hutchison Award! The award, presented by @fredhutch.org SPAC and named for Dr. Nancy Hutchison, recognizes phenomenal mentorship. It also comes with an awesome personalized bobblehead.
Reposted by Fred Hutch
In time for #ASH25, glad to be able to share this work in #TCT.
🔑 1. For many pts, barrier to HCT/CAR T isn't medical, but instead logistical issues like needing a caregiver or local housing.
🔑 2. These reqs aren't well tracked & vary widely between centers
www.sciencedirect.com/science/arti...
🔑 1. For many pts, barrier to HCT/CAR T isn't medical, but instead logistical issues like needing a caregiver or local housing.
🔑 2. These reqs aren't well tracked & vary widely between centers
www.sciencedirect.com/science/arti...
www.sciencedirect.com
December 6, 2025 at 12:48 AM
In time for #ASH25, glad to be able to share this work in #TCT.
🔑 1. For many pts, barrier to HCT/CAR T isn't medical, but instead logistical issues like needing a caregiver or local housing.
🔑 2. These reqs aren't well tracked & vary widely between centers
www.sciencedirect.com/science/arti...
🔑 1. For many pts, barrier to HCT/CAR T isn't medical, but instead logistical issues like needing a caregiver or local housing.
🔑 2. These reqs aren't well tracked & vary widely between centers
www.sciencedirect.com/science/arti...
Fred Hutch at #ASH25: Catch Dr. Christopher Su discuss adverse financial events and delayed treatment initiation among patients with hematologic malignancies. 👉 https://bit.ly/3MHg8Y7
December 6, 2025 at 5:35 PM
Fred Hutch at #ASH25: Catch Dr. Christopher Su discuss adverse financial events and delayed treatment initiation among patients with hematologic malignancies. 👉 https://bit.ly/3MHg8Y7
Fred Hutch at #ASH25: Catch Dr. Motoko Koyama present " IFNγ-driven MHC class II expression by intestinal epithelial cells dictates local cytolytic Th1 cell differentiation and intestinal stem cell loss" 👉 https://bit.ly/4rFnrzM
December 6, 2025 at 4:00 PM
Fred Hutch at #ASH25: Catch Dr. Motoko Koyama present " IFNγ-driven MHC class II expression by intestinal epithelial cells dictates local cytolytic Th1 cell differentiation and intestinal stem cell loss" 👉 https://bit.ly/4rFnrzM
Fred Hutch #BMT and #GVHD expert Dr. Geoffrey Hill spoke to Fred Hutch News about the lifesaving strides that have been made in GVHD treatment, and where the research is focused next. Read more: https://bit.ly/48FyccO
December 6, 2025 at 3:59 PM
Fred Hutch #BMT and #GVHD expert Dr. Geoffrey Hill spoke to Fred Hutch News about the lifesaving strides that have been made in GVHD treatment, and where the research is focused next. Read more: https://bit.ly/48FyccO
Fred Hutch at #ASH25: Catch @aportugu.bsky.social present: "Real-world outcomes with elranatamab in multiple myeloma: A multi-center analysis from the United States multiple myeloma immunotherapy consortium." 👉 https://bit.ly/3MkulKu
December 6, 2025 at 2:00 PM
Fred Hutch at #ASH25: Catch @aportugu.bsky.social present: "Real-world outcomes with elranatamab in multiple myeloma: A multi-center analysis from the United States multiple myeloma immunotherapy consortium." 👉 https://bit.ly/3MkulKu
Fred Hutch at #ASH25: Catch Dr. Marie Bleakely discuss graft engineering and post-transplantation T cell #immunotherapy strategies for minimizing serious #GVHD and preventing relapse of hematological malignancies. 👉 https://bit.ly/4rEPGP2
December 6, 2025 at 1:00 PM
Fred Hutch at #ASH25: Catch Dr. Marie Bleakely discuss graft engineering and post-transplantation T cell #immunotherapy strategies for minimizing serious #GVHD and preventing relapse of hematological malignancies. 👉 https://bit.ly/4rEPGP2
Join us in congratulating Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology program, on receiving prestigious graduate awards from @ash.hematology.org! #ASH25
Read more: https://bit.ly/4rLo3UA
Read more: https://bit.ly/4rLo3UA
December 5, 2025 at 11:26 PM
Join us in congratulating Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology program, on receiving prestigious graduate awards from @ash.hematology.org! #ASH25
Read more: https://bit.ly/4rLo3UA
Read more: https://bit.ly/4rLo3UA